The global allergy diagnosis market is developing significantly with an expected CAGR of above 7.5% from 2019 - 2029. Advances in technological processes are the key growth factor. Skin prick test (SPT) has been highly recommended by European doctors as it is more accurate & least expensive., Introduction of various kinds of kits and instruments have simplified the process of skin prick test (SPT) in the recent years., This led to increase in the revenues and created significant market opportunities. 

Allergy is the immune reaction to foreign body called allergen; it may arise due to food consumed or inhaled into lungs or in contact with skin through injectable agent or touch. Allergic diseases rank fifth among the leading chronic diseases across all age groups in U.S. Over the period of 50 years of global industrialization, there is a substantial rise in prevalence of allergic diseases. According to the World Allergy Organization (WAO) study, the prevalence of allergy ranges from 10% - 40% across all age groups of population. Allergic disease affects more than one billion people worldwide and is anticipated to reach 4 billion in 2050. This increases both direct and indirect burden in terms of rise in healthcare cost, loss of productivity and adverse effect on quality of life. Thus increase in prevalence of allergic diseases and novel diagnostic and treatment products entering the market are the key factors governing the growth of allergy diagnostics and treatment market. 

Manufacturers dominate the market in terms of revenue 

Developing markets & investments in research technology has led to tremendous growth in revenues. Huge increase in home therapy along with anti-side effect drugs impacted the sales in terms of demand. FDA has approved selling of kits through retail channels has been a boon to retailers as well as local manufacturers. Increasing developments with respect to healthcare infrastructure and emerging regulatory framework in developing economies such as China and India are expected to have significant impact on market revenues. 

SPT Test growth adoption 

The Allergy test uses methods such as skin prick test, intradermal skin test, epicutaneous test, blood test, special challenged test and so on. STP method is utilized to diagnose allergic patents with rhinoconjunctivitis, asthma (lung allergy), atopic eczema, food & drug allergy. SPT is a vivo test type carried out on individuals. In future the method is expected to lead tremendous growth referable to inexpensive cost, immediate results and precision. Demand for the test & manufacturing kits has an upward curve globally. Immunotherapy an alternative treatment for allergy is is emerging due to increasing innovation and technology. 

Competitive Analysis by area 

North America acquired the largest share in 2019, followed by Europe & Asia pacific, and the region is expected to remain strong during the 2019-2029. U.S. remains the key geographic region for allergy testing& treatment, the country offers a wide range of services, including scientific and manufacturing research. Factors driving the market are aging population, change in lifestyle & eating habits, emerging technologies, developing infrastructure, global warming. Developing and under developed countries have higher incidence rate due to increase in population, poverty, lack of nutrients, lack of awareness. Increasing incidences of chronic disease in developed countries are expected to raise the focus on technological advancements during the forecast period, 2019 to 2029. The report discusses impact of covid-19 over the market revenues and operational impact by geography in further detail. 

Global Allergy treatment market players 

The top companies in this market include bioMerieux, Siemens healthcare, Hitachi chemical diagnostics, Danaher Corporation, Thermo Fisher Scientific, Omega Diagnostic group, Lincoln Diagnostics, Staller genes Greer, Johnson & Johnson services, CiplaInc, AurobindoPharma, ZydusCadila , Lupin, DrReddys Laboratories, Sun Pharmaceutical. 

Historical & Forecast Period

This study report represents analysis of each segment from 2022 to 2032 considering 2023 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2024 to 2032.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Allergy Diagnostic And Treatment market are as follows:

• Research and development budgets of manufacturers and government spending
• Revenues of key companies in the market segment
• Number of end users and consumption volume, price and value.
• Geographical revenues generate by countries considered in the report
• Micro and macro environment factors that are currently influencing the Allergy Diagnostic And Treatment market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Key questions answered in this report

• What are the key micro and macro environmental factors that are impacting the growth of Allergy Diagnostic And Treatment market?
• What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
• Estimated forecast and market projections up to 2032.
• Which segment accounts for the fastest CAGR during the forecast period?
• Which market segment holds a larger market share and why?
• Are low and middle-income economies investing in the Allergy Diagnostic And Treatment market?
• Which is the largest regional market for Allergy Diagnostic And Treatment market?
• What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
• Which are the key trends driving Allergy Diagnostic And Treatment market growth?
• Who are the key competitors and what are their key strategies to enhance their market presence in the Allergy Diagnostic And Treatment market worldwide?